CBDY
Target Group Inc.Company Information
- Company Name
- Target Group Inc.
- CIK
- CIK0001586554
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- CBDY: OTC
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2833
- SIC Description
- Medicinal Chemicals & Botanical Products
- Ticker
- CBDY
SEC filing data through
Insider Sentiment
- Last purchase
- —
- Last sale
- 2019-03-18
- Shares purchased (TTM)
- 0
- Shares sold (TTM)
- 32,500
Institutional Sentiment
- As of
- —
- Institutional shares owned
- —
- Shares outstanding
- —
- Ownership
- —
Earnings Market Reaction
- Filing date
- 2026-08-13
- Price on filing date
- —
- 1-month reaction
- -8.33%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash | 0 | 0 | 0 | 0 | 1 | 1 | 2 | 1 | 2 | 1 | 1 | 0 | ||||||
| Restricted Cash | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Accounts Receivable Net Current | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | ||||||
| Inventory Net | 2 | 2 | 2 | 1 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 2 | ||||||
| Prepaid Expense Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss Current | - | - | - | - | 0 | 0 | 0 | 0 | - | - | - | - | ||||||
| Interest Receivable Current | - | - | - | - | 0 | 0 | 0 | 0 | - | - | - | - | ||||||
| Value Added Tax Receivable Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | 0 | ||||||
| Other Receivables | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Other Assets Current | 0 | 0 | 0 | - | - | - | 0 | - | - | - | 0 | - | ||||||
| Assets Current | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 3 | 3 | 2 | 3 | 3 | ||||||
Assets Noncurrent | ||||||||||||||||||
| Property Plant And Equipment Net | 3 | 3 | 4 | 4 | 4 | 4 | 4 | 5 | 5 | 5 | 5 | 5 | ||||||
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Operating Lease Right Of Use Asset | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Assets Noncurrent | 3 | 4 | 4 | 4 | 4 | 4 | 4 | 5 | 5 | 5 | 6 | 6 | ||||||
| Assets | 6 | 6 | 6 | 6 | 7 | 7 | 8 | 8 | 8 | 7 | 9 | 8 | ||||||
Liabilities | ||||||||||||||||||
| Bank Overdrafts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Accounts Payable And Accrued Liabilities Current | 3 | 3 | 3 | 2 | 2 | 2 | 3 | 3 | 3 | 2 | 3 | 3 | ||||||
| Deferred Revenue Current | - | 0 | 0 | 0 | - | - | - | 0 | 0 | 0 | 0 | - | ||||||
| Sales And Excise Tax Payable Current | - | - | 0 | - | - | - | 0 | - | - | - | 0 | - | ||||||
| Operating Lease Liability Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Convertible Notes Payable Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Derivative Liabilities Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Liabilities Current | 14 | 14 | 13 | 13 | 10 | 12 | 13 | 13 | 13 | 13 | 15 | 8 | ||||||
| Accounts Payable Interest Bearing Noncurrent | - | - | - | - | 3 | - | - | - | - | - | - | 6 | ||||||
Liabilities Noncurrent | ||||||||||||||||||
| Operating Lease Liability Noncurrent | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Liabilities Noncurrent | 1 | 1 | 1 | 1 | 4 | 1 | 1 | 1 | 1 | 1 | 1 | 7 | ||||||
| Liabilities | 14 | 15 | 14 | 14 | 14 | 13 | 14 | 15 | 14 | 14 | 16 | 15 | ||||||
Stockholders Equity | ||||||||||||||||||
| Derivative Liabilities Noncurrent | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | ||||||
| Retained Earnings Accumulated Deficit | -33 | -33 | -32 | -32 | -31 | -31 | -31 | -31 | -31 | -31 | -31 | -31 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | ||||||
| Stockholders Equity | -9 | -9 | -8 | -7 | -7 | -7 | -7 | -7 | -6 | -7 | -7 | -7 | ||||||
| Liabilities And Stockholders Equity | 6 | 6 | 6 | 6 | 7 | 7 | 8 | 8 | 8 | 7 | 9 | 8 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialTarget Group Inc. (CBDY) — SEC Financial Statements & Analysis
Target Group Inc. (CBDY) is a medicinal chemicals & botanical products company, incorporated in DE. Target Group Inc. trades on OTC as: CBDY. Target Group Inc. (CBDY)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-13. Based on that filing, Target Group Inc. carries a market cap of $555.32K, a P/E ratio of -0.30x, a P/B ratio of -0.06x, a P/S ratio of 0.14x, an enterprise value of $541.80K, and an EV/EBITDA multiple of 2.76x. On profitability, it posts a gross margin of 34.15%, an operating margin of -45.36%, a net margin of -45.36%, a Return on Equity (ROE) of 23.23%, and a Return on Assets (ROA) of -29.70%. Per share, it reports EPS of $-0.00, diluted EPS of $-0.00, free cash flow per share of $-0.00, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of -27.80% year-over-year, net income growth of 184.23% year-over-year, and EPS growth of 184.23% year-over-year. On the balance sheet, it maintains a current ratio of 0.17x, a quick ratio of 0.05x, working capital of $-11.23M, a debt-to-equity ratio of -1.66x, a debt ratio of 2.52, an interest coverage ratio of -0.65x, free cash flow of $-1.07M (TTM), and net debt of $-13.53K. Figures sourced from SEC EDGAR.
- Market Cap
- $555.32K
- P/E TTM
- -0.30x
- EPS TTM
- $-0.00
- P/B TTM
- -0.06x
- ROE TTM
- 23.23%
- ROA TTM
- -29.70%
- Debt To Equity
- -1.66x
- Free Cash Flow TTM
- $-1.07M
- Net Revenue TTM Growth 1Y
- -27.80%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Target Group Inc. in?
Target Group Inc. (CBDY) operates in the Medicinal Chemicals & Botanical Products industry.
What exchange does CBDY trade on?
Target Group Inc. (CBDY) trades on the OTC.
Where is Target Group Inc. incorporated?
Target Group Inc. is incorporated in DE.
When was Target Group Inc. (CBDY)'s most recent SEC filing?
Target Group Inc. (CBDY)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-13.
What is CBDY's market cap?
Target Group Inc. (CBDY) has a market capitalization of $555.32K as of 2026-06-30.
What is CBDY's EPS (earnings per share)?
Target Group Inc. (CBDY)'s trailing twelve month EPS is $-0.00 as of 2026-06-30.
What is CBDY's ROE (return on equity)?
Target Group Inc. (CBDY)'s trailing twelve month Return on Equity (ROE) is 23.23% as of 2026-06-30.
What is CBDY's ROA (return on assets)?
Target Group Inc. (CBDY)'s trailing twelve month Return on Assets (ROA) is -29.70% as of 2026-06-30.
What is CBDY's EV/EBITDA?
Target Group Inc. (CBDY)'s trailing twelve month EV/EBITDA is 2.76x as of 2026-06-30.